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Summary
Objective: Disruption of the vascular supply to the bone and subsequent hypoxia has been implicated in the pathogenesis of osteonecrosis
(ON) of the femoral head (ONFH). To evaluate the genetic effect of HIF1a, a key transcription factor in controlling hypoxia condition, on ONFH,
we analyzed HIF1a polymorphism and its genetic association with ONFH.
Methods: We directly sequenced the HIF1a gene in 24 Korean individuals and identiﬁed four sequence variants. Four polymorphisms
(2755C>A, þ41224T>C, þ45319C>T, þ51610C>T) were genotyped in ONFH (n¼ 384). ONFH patients were divided into three sub-
groups based on etiological factors: idiopathic (129 cases), steroid (59 cases) and alcohol (196 cases) ON groups.
Results: We found that the allele frequency of 2755C>A and the genotype frequencies of þ41224T>C and þ51610C>T were signiﬁcantly
associated with idiopathic ONFH in men (P¼ 0.0409, 0.0113, 0.0269, respectively). In addition, haplotype (CTCC) of HIF1a was also signif-
icantly associated with idiopathic ONFH in men (P¼ 0.017).
Conclusions: We found that HIF1a polymorphisms are associated with idiopathic ONFH in men. These results suggest that variations in
HIF1a may play an important role in the pathogenesis and risk factor for ONFH.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyIntroduction
Osteonecrosis (ON) of the femoral head (ONFH), also com-
monly referred to as avascular necrosis, is a bone disease
that commonly affects middle-aged men between 30 and 50
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2006.688years of age. Trauma is the most common cause of ON1.
For non-traumatic cases, there often remains a diagnostic
challenge in deﬁning the cause of ON. Non-traumatic
ONFH has been associated with corticosteroid usage, alco-
holism, infections, marrow inﬁltrating diseases, coagulation
defects, and some autoimmune diseases1e4. These risk
factors are closely related with direct and indirect injury to
the vascular supply to the bone.
By reduction or disruption of the blood supply to the bone,
the bone marrow dies, eventually causing the bone to col-
lapse. Failure of blood ﬂow results in the lack of oxygen
supply to the bone3,4. Hypoxia can induce both apoptosis
as well as necrosis of cells and is associated with vascular
689Osteoarthritis and Cartilage Vol. 15, No. 6Table I
Clinical profiles of the ONFH patients in the study
Total (N¼ 384) Idiopathy (n¼ 129) Alcohol-induced (n¼ 196) Steroid-induced (n¼ 59) Py
Age [mean (range)]** 46.7 (19e80) 43.9 49.7 42.9 0.017
Sex (male/female)** 306/78 81/48 191/5 34/25 <0.001
Concurrent or past medical history
Hypertension 28 (7.3%) 11 (8.5%) 12 (6.1%) 5 (8.4%) 0.667
Hyperlipidemia 5 (1.3%) 3 (2.3%) 1 (0.8%) 1 (1.7%) 0.354
Diabetes mellitus 16 (4.2%) 4 (3%) 11 (5.6%) 1 (1.7%) 0.317
Renal diseases (transplantation) 16 (9) (27%) 0 (0%) 0 (0%) 16 (9) (27%) <0.001
SLE* 9 (2.3%) 0 (0%) 0 (0%) 9 (2.3%) <0.001
BMI (kg/m2) 23.82 8.44 23.48 2.67 24.38 11.46 22.71 3.10 0.354
*P< 0.05, **P< 0.001 for difference between total patients and controls.
yP values between groups deﬁned according to etiological factor.disease. HIF1 is a master transcription regulator induced by
hypoxia and critically acts in a wide range of cellular regula-
tion processes including glycolysis, apoptosis, erythropoie-
sis, and angiogenesis5e9. The functional HIF1 is composed
of two subunits, HIF1a and HIF1b (aryl hydrocarbon recep-
tor nuclear translocator, ARNT ), with the HIF1a subunit be-
ing responsive to hypoxia. The active subunit HIF1a confers
oxygen sensitivity and is constitutively synthesized, hydrox-
ylated under normoxic conditions before its degradation
through the proteasome complex. Under hypoxia HIF1a is
stabilized, translocates in the nucleus and transactivates
a number of downstream target genes8,10, including vascu-
lar endothelial growth factor (VEGF ), Fms-like tyrosine
kinase1 (FLT1) and plasminogen activator inhibitor type-1
(PAI-1), which are involved in angiogenesis9,11,12. Signiﬁ-
cantly, HIF1a target genes such as VEGF and PAI-1 are
highly expressed in the edematous area of ONFH and dys-
baric ON, respectively13e15. In addition, ONFH is related to
thrombophilia or hypoﬁbrinolysis along with coagulation,and coagulation-related factors such as PAI-1 and methyle-
netetrahydrofolate reductase (MTHFR) are associated with
ONFH development16e18.
Several studies have shown that HIF1a plays an impor-
tant role in growth plate morphogenesis19, fracture heal-
ing20, and distraction osteogenesis21. The presence of the
HIF1 complex in growth plate chondrocytes was demon-
strated to be necessary for both the survival of hypoxic
chondrocytes and normal long bone development in
mice19. In addition, during bone formation typically seen in
fracture repair or distraction osteogenesis, the expressions
of HIF1a and its transcriptionally targeted gene, VEGF, are
directly correlated to cellular survival, blood vessel and cal-
lus formation20,21.
Thus, HIF1a may be of great value in the diagnosis
and therapy of bone disease. In the present study, we
performed an extensive screening to identify HIF1a poly-
morphisms and the association analysis of HIF1a polymor-
phisms, to assess genetic effect on risk of ONFH.B
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Frequencies of HIF1a polymorphism between ONFH patients and controls
Loci* Position rs# Genotype Frequencyy HWE
Case Control
2755C>A Promoter rs1535679 C CA A N 0.439 0.763 0.975
197 303 121 621
þ41224>C Intron8 rs10873142 T TC C N 0.254 0.720 0.543
343 232 40 615
þ45319C>T Exon12 rs11549465 C CT T N 0.047 0.638 0.781
563 54 2 619
þ51610C>T 30_UTR rs2057482 C CT T N 0.194 0.701 0.599
398 191 23 612
*Calculated from the translational start site.
yFrequencies of rare alleles.Materials and methods
SUBJECTS
Blood samples and records were obtained from 237 con-
trols (151 men, 86 women; mean age, 39.8 years ranging
22e68 years) and 384 ONFH (306 men, 78 women;
mean age, 49.4 years ranging 19e80 years) patients who
visited Kyungpook National University Hospital (Daegu,
Korea) from 2002 to 2005. The diagnosis of symptomatic
ON was made using anteroposterior and lateral pelvic
radiographs and magnetic resonance images. According
to etiological factors, patients were subgrouped into idio-
pathic (129 cases), steroid-induced (59 cases), and alcohol-
induced (196 cases) ON groups. Patients with a demonstra-
ble history of direct trauma or with possible combined
causes were excluded. Steroid-induced ON was deﬁned
by a history of taking prednisolone 1800 mg or an equiva-
lent over 4 weeks with nephritic syndrome, and organ trans-
plantation22 and alcohol-induced ON was diagnosed by the
more than 400 ml of pure ethanol consumption per week23.The characteristics of the patients are summarized in Table I.
There were no signiﬁcant differences between patients
and normal controls in terms of concurrent or past medical
histories except renal diseases and systemic lupus erythe-
matosus (SLE). All individuals gave informed consent for
study participation and the studywas approved by our Institu-
tional Review Board.
POLYMERASE CHAIN REACTION (PCR) AMPLIFICATION
AND SEQUENCING ANALYSIS
Genomic DNA was isolated from peripheral blood leuko-
cytes using a FlexiGene DNA Kit (QIAGEN, Valencia, CA,
USA). All PCR reactions were performed in a 25 ml volume
containing 1 PCR buffer (Solgent, Korea), 2 mM deoxy
nucleotide triphosphate (dNTP), oligonucleotide primer
mix (5 pM each of forward and reverse primer), 1 U/ml Taq
DNA polymerase (Solgent, Korea), and 20 ng genomic
DNA. The PCR products were cleaned using an ExoSAP
IT Kit (USB Corp., Cleveland OH, USA). We sequencedTable III
Genotype and allele frequencies of the polymorphisms in HIF1a gene between the ONFH subtype patients and controls
Position Genotype Control n (%) ONFH n (%) P
Alc* Idiy Stez vs Alc Idi Ste
2755C>A CC 78 (33) 63 (32) 36 (28) 20 (34) 0.951 0.244 0.985
CA 117 (49) 96 (49) 61 (47) 29 (49)
AA 42 (18) 37 (19) 32 (25) 10 (17)
C 273 (58) 222 (57) 133 (52) 69 (58) 0.783 0.120 0.917
A 201 (42) 170 (43) 125 (48) 49 (42)
þ41224T>C TT 135 (57) 116 (59) 64 (50) 28 (50) 0.774 0.373 0.441
TC 84 (36) 68 (35) 55 (43) 25 (45)
CC 17 (7) 11 (6) 9 (7) 3 (5)
T 354 (75) 300 (77) 183 (71) 81 (72) 0.523 0.332 0.549
C 118 (25) 90 (23) 73 (29) 31 (28)
þ45319C>T CC 219 (93) 177 (91) 115 (89) 52 (88) 0.430 0.484 0.382
CT 16 (7) 18 (9) 13 (10) 7 (12)
TT 1 (0) 0 (0) 1 (1) 0 (0)
C 454 (96) 372 (95) 243 (94) 111 (94) 0.610 0.263 0.309
T 18 (4) 18 (5) 15 (6) 7 (6)
þ51610C>T CC 156 (67) 132 (68) 75 (58) 35 (63) 0.802 0.161 0.826
CT 68 (29) 55 (28) 50 (39) 18 (32)
TT 10 (4) 6 (3) 4 (3) 3 (5)
C 380 (81) 319 (83) 200 (78) 88 (79) 0.594 0.247 0.508
T 88 (19) 67 (17) 58 (22) 24 (21)
*Alcohol-induced.
yIdiopathy.
zSteroid-induced.
691Osteoarthritis and Cartilage Vol. 15, No. 6
T
a
b
le
IV
L
o
g
is
tic
a
n
a
ly
si
s
o
f
H
IF
1
a
p
o
ly
m
o
rp
h
is
m
s
b
e
tw
e
e
n
O
N
F
H
p
a
tie
n
ts
a
n
d
c
o
n
tr
o
ls
in
m
e
n
S
u
b
g
ro
u
p
s
L
o
c
i
N
o
rm
a
l
c
o
n
tr
o
ls
O
N
F
H
p
a
tie
n
ts
C
o
d
o
m
in
a
n
ts
D
o
m
in
a
n
t
R
e
c
e
s
si
v
e
A
lle
le
O
R
*
(9
5
%
C
I)
P
y
O
R
(9
5
%
C
I)
P
O
R
(9
5
%
C
I)
P
O
R
(9
5
%
C
I)
P
n
¼
1
5
1
n
¼
1
9
1
A
lc
o
h
o
l
2
7
5
5
C
>
A
0
.4
1
0
.4
3
1
.1
0
(0
.8
2
e
1
.4
8
)
0
.5
3
1
1
.2
6
(0
.8
1
e
1
.9
7
)
0
.3
0
8
0
.9
8
(0
.5
7
e
1
.6
8
)
0
.9
3
3
1
.1
1
(0
.8
2
e
1
.5
)
0
.5
1
7
þ4
1
2
2
4
T
>
C
0
.2
4
0
.2
3
0
.9
6
(0
.6
8
e
1
.3
5
)
0
.5
2
8
1
.0
2
(0
.6
6
e
1
.5
8
)
0
.9
2
2
0
.6
5
(0
.2
8
e
1
.4
9
)
0
.3
0
4
0
.9
4
(0
.6
6
e
1
.3
4
)
0
.7
2
0
þ4
5
3
1
9
C
>
T
0
.0
5
0
.0
5
1
.0
3
(0
.5
1
e
2
.0
9
)
0
.4
7
7
1
.1
0
(0
.5
2
e
2
.3
3
)
0
.7
9
7
0
.0
0
(0
.0
0
)
0
.2
6
0
1
.0
2
(0
.5
e
2
.1
)
0
.9
6
6
þ5
1
6
1
0
C
>
T
0
.1
9
0
.1
7
0
.9
1
(0
.6
2
e
1
.3
2
)
0
.4
5
5
0
.9
4
(0
.6
0
e
1
.4
9
)
0
.8
0
2
0
.5
2
(0
.1
8
e
1
.4
9
)
0
.2
1
3
0
.8
7
(0
.6
e
1
.3
)
0
.4
9
3
n
¼
1
5
1
n
¼
8
1
Id
io
p
a
th
y
2
7
5
5
C
>
A
0
.4
1
0
.5
1
1
.4
3
(0
.9
9
e
2
.0
7
)
0
.1
5
4
1
.6
3
(0
.9
0
e
2
.9
3
)
0
.1
0
5
1
.6
7
(0
.8
9
e
3
.1
3
)
0
.1
1
0
1
.5
(1
.0
2
e
2
.1
9
)
0
.0
4
1
þ4
1
2
2
4
T
>
C
0
.2
4
0
.2
9
1
.2
8
(0
.8
3
e
1
.9
6
)
0
.0
1
1
1
.7
8
(1
.0
3
e
3
.0
8
)
0
.0
3
7
0
.4
1
(0
.1
1
e
1
.4
7
)
0
.1
5
6
1
.2
7
(0
.8
3
e
1
.9
5
)
0
.2
7
4
þ4
5
3
1
9
C
>
T
0
.0
5
0
.0
6
1
.1
8
(0
.5
3
e
2
.6
6
)
0
.8
9
1
1
.1
5
(0
.4
6
e
2
.9
1
)
0
.7
6
0
1
.8
6
(0
.1
1
e
3
0
.1
8
)
0
.6
5
7
1
.2
(0
.5
1
e
2
.8
5
)
0
.6
7
5
þ5
1
6
1
0
C
>
T
0
.1
9
0
.2
4
1
.3
3
(0
.8
4
e
2
.1
0
)
0
.0
2
7
1
.7
3
(1
.0
0
e
3
.0
2
)
0
.0
5
1
0
.4
0
(0
.0
8
e
1
.8
8
)
0
.2
2
9
1
.3
2
(0
.8
4
e
2
.1
)
0
.2
3
3
n
¼
1
5
1
n
¼
3
4
S
te
ro
id
2
7
5
5
C
>
A
0
.4
1
0
.4
1
1
.0
2
(0
.6
1
e
1
.7
0
)
0
.9
1
3
1
.1
1
(0
.5
1
e
2
.4
2
)
0
.7
8
9
0
.9
0
(0
.3
4
e
2
.3
8
)
0
.8
3
4
1
.0
2
(0
.6
e
1
.7
4
)
0
.9
4
6
þ4
1
2
2
4
T
>
C
0
.2
4
0
.2
7
1
.1
7
(0
.6
6
e
2
.0
6
)
0
.4
5
9
1
.4
1
(0
.6
6
e
3
.0
1
)
0
.3
7
1
0
.6
8
(0
.1
5
e
3
.1
7
)
0
.6
2
1
1
.1
7
(0
.6
4
e
2
.1
3
)
0
.6
1
7
þ4
5
3
1
9
C
>
T
0
.0
5
0
.0
6
1
.2
7
(0
.4
2
e
3
.8
2
)
0
.7
0
2
1
.4
1
(0
.4
3
e
4
.6
1
)
0
.5
7
3
0
.0
0
(0
.0
0
)
0
.6
3
3
1
.2
8
(0
.4
1
e
4
.0
0
)
0
.6
7
5
þ5
1
6
1
0
C
>
T
0
.1
9
0
.2
1
.0
4
(0
.5
5
e
1
.9
6
)
0
.6
3
0
1
.1
8
(0
.5
4
e
2
.5
9
)
0
.6
8
3
0
.4
9
(0
.0
6
e
4
.0
0
)
0
.4
9
7
1
.0
2
(0
.5
2
e
2
.0
0
)
0
.9
4
6
*L
o
g
is
tic
re
g
re
s
si
o
n
a
n
a
ly
s
e
s
w
e
re
u
s
e
d
fo
r
c
a
lc
u
la
tin
g
O
R
(9
5
%
C
I)
.
yV
a
lu
e
s
w
e
re
a
n
a
ly
ze
d
b
y
c
2
te
s
t.
B
o
ld
:
P
v
a
lu
e
<
0
.0
5
.all exons and their boundaries of the HIF1a gene, including
the promoter region (w1.5 kb), to discover genetic variants
in 24 Korean DNA samples using a DYEnamic ET Dye ter-
minator Kit and a DNA analyzer (MegaBace 1000, Amer-
sham Biosciences, GE Healthcare Bio-Sciences Corp,
Piscataway, NJ, USA).
GENOTYPE ANALYSIS
Genotyping was performed by the single-base extension
(SBE) method with a MegaBace SNuPe kit (Amersham Bio-
sciences). The SBE reaction mixture was prepared accord-
ing to the manufacturer’s instructions. The primer extension
reaction was performed at 96 C for 1 min, followed by 25
cycles at 96 C for 10 s, 50 C for 5 s, and 60 C for 10 s.
To clean up the primer extension reaction, 1 unit of shrimp
alkaline phosphatase (USB Corp.) was added to the reac-
tion mixture, and the mixture was incubated at 37 C for
90 min, followed by 15 min at 80 C for enzyme inactivation.
The loading solution containing injection marker was added
to inactivate the SNuPe reaction mixtures according to the
recommendations of the manufacturer, and the electropho-
resis was analyzed by a MegaBace gene scan and SNP
proﬁler program (Amersham Biosciences).
STATISTICAL ANALYSIS
Statistical analysis was based on the frequency of alleles
and genotypes between the controls and ONFH cases. The
HardyeWeinberg equilibrium was tested for each SNP us-
ing the c2 test. Logistical regression analyses were used
to calculate the odds ratios (OR), their 95% conﬁdence in-
terval (CI) for SNP sites. The P values of codominant, dom-
inant and recessive models are given. We employed
a widely used measure of linkage disequilibrium (LD) be-
tween all pairs of biallelic loci, D 0, and r 2. Haplotypes and
their frequencies were constructed with an expectation
maximization (EM) algorithm24 or Permutation test, with
genotyped SNPs. A Fisher’s exact test or c2 test was ap-
plied to compare the frequency of discrete variables be-
tween controls and patients. Continuous variables were
compared by Student’s t test or ANOVA. A P value of
less than 0.05 was considered to be statistically signiﬁcant.
Results
HIF1a is composed of 15 exons spanning 53 kb of geno-
mic DNA. In order to discover polymorphism in the HIF1a
gene, we directly sequenced all exons and their boundaries
of HIF1a including 1500 bp of the 50-ﬂanking regions in 24
randomly selected individuals. Direct sequencing revealed
four SNPs, which were 2755C>A in the promoter,
þ41224T>C in intron, þ45319C>T in exon, and
þ51610C>T in 30 untranslated region (UTR), as deﬁned
by the nucleotide numbering from the translational start
site [Fig. 1(A)]. The genotype frequencies of these four poly-
morphisms did not deviate from the HardyeWeinberg equi-
librium (Table II). We analyzed LDs among these HIF1a
polymorphisms, and found that absolute LDs were not
observed in the HIF1a gene. LD between polymorphisms
was estimated by calculating the D0 values [Fig. 1(B)].
Association study revealed that HIF1a polymorphisms
were not associated with genotype and allele frequencies
between control and alcohol-induced, steroid-induced, or id-
iopathic ONFH (Table III). Since we observed a tendency
showing a high incidence of ONFH in men (306 men vs
692 J. M. Hong et al.: HIF1a polymorphisms and ONFHTable V
The haplotype frequencies of HIF1a polymorphisms between idiopathic ONFH patients and controls in men
Haplotype Frequency* Py
2755C>A þ41224T>C þ45319C>T þ51610C>T Control ONFH (ido-)
C T C C 0.568 0.446 0.017
A T C C 0.182 0.247 0.138
A C C T 0.138 0.196 0.086
A C T T 0.047 0.039 0.642
A C C C 0.042 0.015 0.159
C C C C 0.016 0.041 0.149
Others 0.007 0.016 e
*Values were constructed by EM algorithm with genotyped polymorphisms.
yValues were analyzed by permutation test. Bold: P value < 0.05.78 women), association of HIF1a polymorphisms was fur-
ther analyzed with ONFH subgroups in men. We found
that the allele frequency of 2755C>A between male idio-
pathic ONFH patients and controls was signiﬁcantly associ-
ated (P¼ 0.0409, OR 1.5, 95% CI 1.02e2.19), suggesting
that T allele of 2755C>A contributes to ONFH susceptibil-
ity of men in the idiopathic subgroup. In addition, the geno-
type frequencies of þ41224T>C and þ51610C>T were
signiﬁcantly associated with the idiopathic ONFH subgroup
in codominant and dominant models (P¼ 0.0113e0.0368
and 0.0269e0.0509, respectively) (Table IV).
We also calculated the haplotype frequencies among
2755C>A, þ41224T>C, þ45319C>T, and þ51610C>T
in both idiopathic ONFH subgroup and the controls in men.
The distribution of haplotype CTCC was signiﬁcantly differ-
ent between the male idiopathic ONFH patients and male
controls (P¼ 0.017) (Table V). These results suggest that
the HIF1a polymorphisms might be one of the most impor-
tant genetic factors in idiopathic ONFH susceptibility in men.
Discussion
Although various factors have been implicated in the de-
velopment of ONFH, the disruption of the blood supply to
the femoral head seems to be the major risk factor1,2,17,25.
Hypoxia as a result of decreased blood supply induces
transactivation of HIF1a and subsequently HIF1a binds to
hypoxia response elements (HRE) of the target genes in-
volved in angiogenesis, glucose and energy metabolism26,
cell proliferation, and erythropoiesis12,27. Recently, HIF1a
gene polymorphism (þ45319C>T) has been shown to be
associated with the renal cell carcinoma (RCC) phenotype
and may confer susceptibility involved in RCC and prostate
cancer28e30. þ45319C>T (P582S) is located within the N-
terminal transactivation domain (N-TAD) of the HIF1a pro-
tein, and amino acid changes in the N-TAD might confer
functional changes in the HIF1a protein and therefore affect
the properties of the protein, giving it an increased or de-
creased ability to transactivate and cause transcription of
its target genes30,31. Also, the polymorphism in the pro-
moter, 50 and 30 UTR region of gene alters its transcription
or stability of transcript, and may inﬂuence the target gene
expression. HIF1 directly regulates the expression of sev-
eral genes involved in angiogenesis, such as VEGF, FLT1
(VEGF receptor) and PAI-127. VEGF is important for bone
formation processes, such as normal growth plate morpho-
genesis including blood vessel invasion and cartilage remod-
eling19, and has also been implicated in bone repair20. In
addition, it was reported that decreased ﬁbrinolytic activity
through elevated PAI-1 levels has been implicated in the
pathogenesis of avascular necrosis32.In our study, we for the ﬁrst time accessed association of
HIF1a gene polymorphisms with ONFH. Our results demon-
strate that HIF1a polymorphisms are signiﬁcantly associ-
ated with the idiopathic ONFH subgroup in men. We
classiﬁed the subjects into three subgroups based on etiol-
ogy: alcohol-induced, steroid-induced, and idiopathic group.
Alcohol intake and steroid drug are associated with an in-
creased risk of ONFH2,33,34. Alcohol works by changing
fat metabolism and accumulating cell stress which causes
occlusion of blood ﬂow. Steroid drug induces fat cell en-
largement which in turn causes medullary hypertension
and blood occlusion. In addition, hypoxia leads to enhanced
lipid accumulation35e37. The current data show that there is
signiﬁcant difference in genotype distribution and the CTCC
haplotype of HIF1a gene between ONFH male patients and
controls in the idiopathic ONFH subgroup. It is hypothesized
that the allele and genotype frequencies of 2755C>A,
þ41224T>C, þ51610C>T have affected the haplotype fre-
quency of CTCC in the idiopathic subgroup. There was no
association of HIF1a polymorphisms with alcohol-induced
or steroid-induced ONFH in the current study. This sug-
gests that although hypoxia affects alcohol and steroid me-
tabolism, more sensitive factors related to alcohol or steroid
other than hypoxia play a role in alcohol-induced and ste-
roid-induced ONFH. Our future studies will investigate
these gene polymorphisms related to the development of
ONFH.
In summary, we found that HIF1a polymorphisms are as-
sociated with idiopathic ONFH in men. These results sug-
gest that variations in HIF1a may play a role in the
pathogenesis and risk factor for ONFH.
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